3D bioprinting of collagen-based high-resolution internally perfusable scaffolds for engineering fully biologic tissue systems
Likely the key Replistruder-associated publication; we should extract the repo link from full text.
- Year
- 2025
- Skill
- medium
- Docs
- moderate
- Rubric
- 3.4 / 5
Implementation assessment
Scoring by criterion
Scores describe accessibility and implementation characteristics reported in the reviewed source. They are not a measure of scientific quality.
Resolution
Smallest feature/positioning evidence about 6 um.
Scalability/Throughput
Moderate scalability via modularity, batching, or partial automation.
Build and Part Sourcing Complexity
Part sourcing complexity not explicit; assigned moderate default.
Skill Complexity
Multiple advanced technical skills appear required.
Equipment/Cosumable/Facility Requirement Accessibility
Requires accessible but nontrivial lab/maker equipment.
Application Level
Presented as modular or usable across multiple workflows.
Accessibility to documentation
Some open documentation or files are available.
Validation/Troubleshooting Complexity
Validation includes standards, benchmarking, replicates, or multi-condition tests.
Speed/Cycle Time
Speed evidence suggests rapid, real-time, or automated operation.
Build Time
Build time not reported; assigned neutral score.
Record metadata
Publication data
Crossref and OpenAlex
Publication record
Abstract
Organ-on-a-chip and microfluidic systems have improved the translational relevance of in vitro systems; however, current manufacturing approaches impart limitations on materials selection, non-native mechanical properties, geometric complexity, and cell-driven remodeling into functional tissues. Here, we three-dimensionally (3D) bioprint extracellular matrix (ECM) and cells into collagen-based high-resolution internally perfusable scaffolds (CHIPS) that integrate with a vascular and perfusion organ-on-a-chip reactor (VAPOR) to form a complete tissue engineering platform. We improve the fidelity of freeform reversible embedding of suspended hydrogels (FRESH) bioprinting to produce a range of CHIPS designs fabricated in a one-step process. CHIPS exhibit size-dependent permeability of perfused molecules into the surrounding scaffold to support cell viability and migration. Lastly, we implemented multi-material bioprinting to control 3D spatial patterning, ECM composition, cellularization, and material properties to create a glucose-responsive, insulin-secreting pancreatic-like CHIPS with vascular endothelial cadherin + vascular-like networks. Together, CHIPS and VAPOR form a platform technology toward engineering full organ-scale function for disease modeling and cell replacement therapy.
Bibliographic details
Access and metrics
Topics and keywords
Perspective and practical signals
Why it matters
Likely the key Replistruder-associated publication; we should extract the repo link from full text.
Limitations
No limitation note curated yet.